Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe.
Linda A Mandikiyana ChirimutaMargaret J PascoeSara LowePublished in: Southern African journal of HIV medicine (2022)
Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance.